| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
PLCD1 |
DKFZp686K101: Putative uncharacterized protein DKFZp686K101 |
4.637 |
Evidence |
|
| GADD45B |
GADD45B, MYD118: Growth arrest and DNA-damage-inducible protein GADD45 beta |
NR1D1 |
NR1D1, EAR1, HREV, THRAL: Orphan nuclear receptor NR1D1 |
4.637 |
Evidence |
|
| HNRPR |
HNRPR: Heterogeneous nuclear ribonucleoprotein R |
SYT11 |
SYT11, KIAA0080: Synaptotagmin-11 |
4.637 |
Evidence |
|
| HNRPR |
HNRPR: Heterogeneous nuclear ribonucleoprotein R |
SYT1 |
SYT1, SVP65, SYT: Synaptotagmin-1 |
4.637 |
Evidence |
|
| LIN7A |
LIN7A, MALS1, VELI1: Lin-7 homolog A |
KCNJ6 |
KCNJ6, GIRK2, KATP2, KCNJ7: G protein-activated inward rectifier potassium chann |
4.637 |
Evidence |
|
| LIN7A |
LIN7A, MALS1, VELI1: Lin-7 homolog A |
KCNJ4 |
KCNJ4: Inward rectifier potassium channel 4 |
4.637 |
Evidence |
|
| NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
MAP2K6 |
MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki |
4.635 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
HSP90AA1 |
Hsp89-alpha-delta-N |
4.63 |
Evidence |
|
| RANBP2 |
RANBP2, NUP358: E3 SUMO-protein ligase RanBP2 |
ELAVL1 |
ELAVL1, HUR: ELAV-like protein 1 |
4.63 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
4.63 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
4.63 |
Evidence |
|
| LIG1 |
LIG1: DNA ligase 1 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
4.63 |
Evidence |
|
| VIL2 |
IPI00479359 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
4.63 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
4.63 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
4.63 |
Evidence |
|
| SUPT5H |
SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 |
HSPE1 |
HSPE1: 10 kDa heat shock protein, mitochondrial |
4.63 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
4.625 |
Evidence |
O
|
| NRAS |
NRAS, HRAS1: GTPase NRas precursor |
BAD |
BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death |
4.622 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
PFN1 |
PFN1: Profilin-1 |
4.622 |
Evidence |
|
| SUMO1 |
SUMO1, SMT3C, OK/SW-cl.43, SMT3H3, UBL1: Small ubiquitin-related modifier 1 prec |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
4.62 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
4.617 |
Evidence |
|
| ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
4.587 |
Evidence |
|
| FGF1 |
FGF1, FGFA: Heparin-binding growth factor 1 precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
4.587 |
Evidence |
|
| YIPF5 |
YIPF5, FINGER5, PP12723, YIP1A, SB140, UNQ3123/PRO10275: Protein YIPF5 |
YIF1A |
YIF1A, 54TM, HYIF1P, YIF1: Protein YIF1A |
4.585 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
4.585 |
Evidence |
|
- 
-